ask="N/A"
ask_size="N/A"
average_daily_volume="39387"
bid="12.86"
bid_size="100"
book_value="5.83"
change="-0.05"
change_from_200_day_moving_average="-5.33"
change_from_50_day_moving_average="-2.70"
change_from_52_week_high="-12.82"
change_From_52_week_low="3.52"
change_in_percent="-0.37%"
close="13.54"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="0.40"
ex_dividend_date="N/A"
float_shares="7054000"
high="13.90"
high_52_weeks="26.36"
last_trade_date="3/9/2017"
last_trade_price="13.54"
last_trade_size="407"
last_trade_time="4:00pm"
low="13.50"
low_52_weeks="10.02"
market_capitalization="226.31M"
moving_average_200_day="18.87"
moving_average_50_day="16.24"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="13.76"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-28.23%"
percent_change_from_50_day_moving_average="-16.61%"
percent_change_from_52_week_high="-48.63%"
percent_change_from_52_week_low="+35.13%"
previous_close="13.59"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.33"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="9.96"
stock_exchange="NGM"
symbol="PTGX"
volume="10195"
weeks_range_52="10.02 - 26.36"
